[Basic and clinical aspects of drug resistance in human immunodeficiency virus type 1 infection].
Salomon
H E
HE
McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, Canadá.
Pampuro
S E
SE
Gu
Z
Z
Montaner
J S
JS
Libonatti
O
O
Wainberg
M A
MA
D000328:Adult; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002648:Child; D018450:Disease Progression; D004352:Drug Resistance, Microbial / Q000235:genetics; D018432:Drug Resistance, Multiple / Q000235:genetics; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D054303:HIV Reverse Transcriptase / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D006801:Humans; D015337:Multicenter Studies as Topic; D017354:Point Mutation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology; D014774:Virulence; D015215:Zidovudine / Q000494:pharmacology
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D054303:HIV Reverse Transcriptase